Semaglutide + B12

Weekly GLP-1 weight loss treatment.

Semaglutide is a GLP-1 receptor agonist that has shown remarkable efficacy for weight management, combined with B12 for metabolic and energy support.

How it works

Semaglutide mimics the GLP-1 hormone, slowing gastric emptying, reducing appetite signals in the brain, and improving insulin secretion to support sustainable weight loss.

Benefits

• Clinically proven weight loss
• Appetite reduction
• Improved glycemic control
• Once-weekly dosing
• B12 energy support

Dosing protocol

Start at 0.25mg weekly for 4 weeks, titrate to 0.5mg, then 1mg, up to 2.4mg as tolerated. Weekly subcutaneous injection.

Contraindications

• Personal or family history of thyroid cancer
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Pancreatitis
• Severe GI disease
• Pregnancy

Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. Medications only issued when clinically appropriate after provider evaluation.